The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
Open Access
- 1 December 2010
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 12 (12), 1309-1316
- https://doi.org/10.1093/eurjhf/hfq151
Abstract
Aims Heart failure with normal ejection fraction (HFnEF) is an important clinical entity that remains incompletely understood. The novel biomarker growth differentiation factor 15 (GDF‐15) is elevat...Keywords
This publication has 33 references indexed in Scilit:
- Uncoupled Cardiac Nitric Oxide Synthase Mediates Diastolic DysfunctionCirculation, 2010
- Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection FractionCirculation, 2009
- Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnoverEuropean Journal of Heart Failure, 2009
- Growth-differentiation factor-15 for early risk stratification in patients with acute chest painEuropean Heart Journal, 2008
- Cardiac myocyte gene expression profiling during H2O2-induced apoptosisPhysiological Genomics, 2007
- The Transforming Growth Factor-β Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion InjuryCirculation Research, 2006
- GDF15/MIC-1 Functions As a Protective and Antihypertrophic Factor Released From the Myocardium in Association With SMAD Protein ActivationCirculation Research, 2006
- Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failureEuropean Heart Journal, 2006
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986